Just recently I read this announcement from Baxter International who, in my opinion, is still unquestionably the leader in the plasma protein business. They have made the decision to invest more than $1 billion in a new fractionation plant in Georgia which will include a Purification area, a Filling Suite and a Testing Laboratory. It will create more than 1,500 jobs. The plant will probably fractionate approximately 4 million liters of plasma into finished products, and this is over and beyond the 4 million liters that Baxter already fractionates in its plant in Glendale, California.

My conclusions:
1) The plasma industry is a robust and expanding industry;
2) There will be need for more plasma;
3) There will be more demand for products;
4) Would this be a sign that Baxter’s Phase III Clinical Trial using their IVIG to prevent the growth of Alzheimer’s Disease is showing positive signs?

“Education is the ability to listen to almost anything without losing losing your temper or your self-confidence.”

–Robert Frost,

American poet